Robust and accurate diagnostic tools are required to aid and inform diagnosis of many disease states. Many of these diagnostic tools require protein (e.g. monoclonal antibody) components for their readout. As such, they require biological manufacturing systems to make those reagents. However, when compared to the protein requirements for therapeutics applications, diagnostic products have a significantly lower demand in terms of scalability and absolute amount of protein but still require robustness and reproducibility.
Aragen Bioscience routinely scales down the therapeutic CHO-DG44 cell line development process to meet the needs of diagnostic products.
Whether your diagnostic product requires a standard monoclonal antibody or a complex protein, contact us to discover how our platform can be applied to your protein production needs.